Two, Dean Diagnostics: Dean Diagnostics Group Co., Ltd. was founded in 2001, is a diagnostic services outsourcing as the core business of the third-party independent medical diagnostic services, and in July 2011 in the industry took the lead in the listing (stock code: 300244), realizing China's independent medical laboratories listed on the "zero breakthrough! In July 2011, Dean Diagnostics took the lead in the industry to go public (stock code: 300244), realizing the "zero breakthrough" of listing independent medical laboratories in China, and maintaining a compound growth rate of more than 40% for six consecutive years. Dean Diagnostics is committed to providing customers with "integrated solutions for medical diagnostic services", and actively promotes the expansion of third-party independent medical diagnostic platform in multi-service areas and the integrated development strategy of the upstream and downstream industry chain, with its business covering medical diagnostic services, diagnostic products and services marketing, forensic identification, health examination, cold chain logistics, diagnostic technology R&D and production, CRO, biotechnology and biochemistry. The business covers medical diagnostic services, marketing of diagnostic products and services, forensic identification, health check business, cold chain logistics, diagnostic technology R&D and production, CRO, and biological sample bank.
Three, Huachang Chemical: Jiangsu Huachang Chemical Co., Ltd. is located in Zhangjiagang City, Jiangsu Province in the Yangtze River Delta, is located in the coastal and Yangtze River two major economic development zone intersection, the north of the Yangtze River, south of the Taihu Lake, east of Shanghai, west of Nanjing, close to the Jiangsu Zhangjiagang Free Trade Zone and Zhangjiagang Harbor, land and water transportation is convenient. The company is the core enterprise of Jiangsu Huachang (Group) Co., Ltd, which was founded in 1970, restructured in 1999, and changed into a joint stock limited company as a whole in 2004.
Four, Kaipu biological: Guangdong Kaipu Biotechnology Co., Ltd. is a leading domestic nucleic acid molecular diagnostic products provider, focusing on molecular diagnostic reagents, molecular diagnostic instrumentation, such as in vitro diagnostic products, research and development, production and sales of related products, and provide related services. Based on the inflow hybridization technology platform with independent intellectual property rights and the perfect international common fluorescent PCR quantitative detection technology platform, we have developed a product line covering two major fields of infectious disease detection and genetic disease detection, and targeting the cervical cancer caused by human papillomavirus (HPV) infection, the infectious diseases of the lower genital tract caused by gonococcus/ Chlamydia trachomatis/ ureidoids/ herpesvirus and cytomegalovirus infection, as well as thalassaemia gene, Gram-positive and Gram-associated diseases, and the infectious diseases of the lower genital tract caused by cytomegalovirus infection. diseases, as well as genetic diseases such as thalassemia gene, G6PD, deafness susceptibility gene, phenylketonuria, prenatal diagnosis and newborn disease screening, and nucleic acid molecular testing series products such as early detection of tumors, which are widely used in the fields of clinical testing, large-scale population screening and eugenics management.
V. Xilong Science: Xilong Science Co., Ltd. has been committed to the research and development, production and sales of chemical reagents, after more than 30 years of development, on the basis of chemical reagents, has expanded to the field of biological reagents to form a general reagents, PCB electronic chemicals, ultra-clean and high-purity solvents, biological reagents, 4 business segments, and supplemented by APIs, food additives, laboratory products and chemical raw materials in one high-tech. Chemical raw materials as one of the high-tech product chain and industry group; at the same time, the company's marketing service network covering the domestic and Asia-Pacific region, with marketing branches and offices **** 41, has developed into a domestic chemical reagent R & D capabilities, sales coverage, comprehensive supporting scale leading professional manufacturers and integrated suppliers.
Sixth, the spotlight technology: spotlight technology (Hangzhou) Co., Ltd. (stock code: 300203) is the return of foreign students founded by the high-tech enterprises, registered in January 2002 was established in Hangzhou City, Zhejiang Province, the National High-tech Industrial Development Zone, listed on April 15, 2011, with a registered capital of 453 million yuan RMB, is the domestic advanced urban intelligence overall It is an advanced total solution provider of urban intelligentization in China, and one of the pioneers in the construction of green intelligent cities in China. The company has a R&D team of more than 500 people, all of whom have bachelor's degree or above, including more than 40% of masters and doctors, and has been recognized as "National Enterprise Technology Center" and "National Engineering and Technology Center for Environmental Protection Monitoring Instruments", The company has been recognized as "National Enterprise Technology Center", "National Engineering Technology Center for Environmental Protection Monitoring Instruments", "Engineering Technology Application Center for Urban Water Pollution Control", "National Engineering Laboratory for Environment and Safety On-line Detection Technology", and "Key Software Enterprise within the Layout of National Planning", National Innovative Enterprise", "State-level Postdoctoral Research Station", "Zhejiang Provincial Academician Expert Workstation", "Zhejiang Provincial Key Enterprise Research Institute", etc. Research Institute", etc.
Seven, Meinian Health: Meinian Health Industry Holding Co., Ltd. was founded in 2004, is China's well-known professional health checkups and medical services group in 2017 has 20 million people to provide professional health services, in 2018 will be more than 30 million people to provide professional health services. The Group was successfully listed on the A-share market in August 2015 (SZ:002044), and acquired "Mazao" and "Ciming" in 2016 and 2017 respectively, becoming a listed company with outstanding market capitalization and influence in the medical and healthcare sector.
Eight, Daan Gene: Zhongshan University Daan Gene Co., Ltd. relying on the strong scientific research platform of Sun Yat-sen University, is a molecular diagnostic technology-led, set of clinical testing reagents and instruments, research and development, production, sales, and the national chain of independent medical laboratory clinical testing services as one of the biomedical high-tech enterprises. The company was listed on the Shenzhen Stock Exchange in August 2004, becoming an early listed company in the university-run industry of Guangdong Province.
Nine, Shanghai Lace: Shanghai Lace Blood Products Co., Ltd. was founded in 1988, listed on the Shenzhen Stock Exchange in 2008 (stock code: 002252), is a well-known blood products enterprises in Asia. Over the past 30 years since its establishment, the company has been adhering to the quality policy of "safety, high quality and high efficiency", and has created 11 products covering three categories of blood products: human blood protein, human immunoglobulin and coagulation factors, with the main products including human albumin, human immunoglobulin, human immunoglobulin for static injection, human immunoglobulin for hepatitis B, human immunoglobulin for tetanus, human immunoglobulin for rabies, and human immunoglobulin for hepatitis B. human immunoglobulin, human immunoglobulin for rabies, human plasminogen complex, human coagulation factor VIII, lyophilized human thrombin, human fibrinogen, and topical lyophilized human fibrin adhesive.
Ten, Yang Pu medical: Guangzhou Yang Pu Medical Technology Co., Ltd. was founded in 1996, 2009 in Shenzhen GEM listing. Since its inception, Yang Pu medical through continuous technological innovation and management innovation, and constantly to the medical device product platform and medical services combined with the group, the internationalization of the company.